Suggestions
Charles Cathlin
CEO / Co-Founder at Polaris Genomics
Professional Background
Charles Cathlin is a trailblazing co-founder and CEO of TruGenomix, a pioneering behavioral health company that harnesses the power of genomics for advancing the diagnosis and treatment of post-traumatic stress disorder (PTSD). Leveraging a wealth of experience as a U.S. military veteran, Charles has dedicated his career to improving the lives of those affected by serious mental health conditions. His impressive career spans over 23 years of active service in both the U.S. Air Force and the U.S. Public Health Service, where he exhibited exemplary leadership skills and a steadfast commitment to public health, medical technology, and engineering.
Upon his retirement from active duty in 2018, Charles Cathlin has become a prominent thought leader in the fields of medical technology and mental health interventions, especially those focusing on the nuances of PTSD. His compelling experiences at ground zero after the September 11th attacks inspired him to shift his focus toward medical innovations that could have a profound impact on psychological health.
Charles’ leadership background is bolstered by his role as Chief of Staff at the Defense and Veterans Brain Injury Center (DVBIC), where he was at the helm of strategic management and operations for the Department of Defense’s largest center of excellence. His responsibilities included overseeing business operations and leading communications for traumatic brain injury (TBI) initiatives, supporting the development of educational products and research designed to benefit military personnel and veterans across 22 treatment facilities.
In addition, Charles served as Director of Innovation and Implementation at the Deployment Health Clinical Center, which is currently known as the Psychological Health Center of Excellence. His role involved spearheading efforts to improve military psychological health treatment modalities and education.
Education and Achievements
Charles Cathlin’s educational accomplishments are as impressive as his professional journey. He began with a Bachelor of Science in Environmental Engineering from the prestigious U.S. Air Force Academy, laying a strong foundation in engineering and science. Driven by a desire to influence public health positively on a global scale, he pursued a Master of Public Health with a focus on International Health from the Uniformed Services University of the Health Sciences (USUHS).
In addition to his formal education, Charles has completed advanced executive post-graduate programs in entrepreneurship at Stanford’s Graduate School of Business and Johns Hopkins University’s Carey Business School. These programs have further equipped him with the knowledge and skills necessary to navigate the intersection of medical technology and innovative business practices, preparing him to lead startups in the rapidly evolving health tech field.
Achievements
Throughout his remarkable career, Charles Cathlin has garnered numerous accolades and experiences that highlight his capabilities as a leader, innovator, and influencer in the health sector. His work at the FDA (Food and Drug Administration) further exemplifies his commitment to the field of medical device regulation. He began his regulatory career with compliance reviews of diagnostic radiological devices and advanced to become the Chief of the Radiology and Neurology Devices Branch, where he played a crucial role in ensuring the safety and efficacy of medical technologies.
In addition to his role at TruGenomix and prior positions within the military and public health services, Charles is a co-founder and board member of Confinis Corporation, a global medical device consulting company that operates both in Switzerland and the United States. His entrepreneurial spirit and expertise in medical device commercialization have further aided in bridging the gap between groundbreaking technologies and accessible healthcare solutions.
Charles Cathlin remains engaged in the entrepreneurial community, having participated in the Illumina Accelerator as an alumni, and he has been involved with the Patriot Boot Camp presented by Techstars, wherein he mentored and guided budding entrepreneurs to navigate the competitive startup landscape. His dedication to fostering innovation and supporting the next generation of entrepreneurs reflects his commitment to the continued evolution of health technology.
With his diverse background, deep-rooted passion for improving mental health interventions, and extensive leadership experience, Charles Cathlin is undoubtedly a key figure in the landscape of behavioral health innovation and medical technology. He is a powerhouse of knowledge and experience and exemplifies the potential of genomic technology in transforming lives for those grappling with the effects of PTSD and other mental health challenges.